Qube Research & Technologies (QRT)’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,273
Closed -$1.1M 4121
2026
Q1
$1.1M Buy
+34,273
New +$1.27M ﹤0.01% 2443
2025
Q4
Sell
-12,714
Closed -$436K 4114
2025
Q3
$436K Sell
12,714
-971,072
-99% -$27.9M ﹤0.01% 2754
2025
Q2
$26.6M Buy
983,786
+163,049
+20% +$4.72M 0.03% 733
2025
Q1
$24.3M Buy
820,737
+370,466
+82% +$14.1M 0.03% 665
2024
Q4
$17.8M Buy
450,271
+45,885
+11% +$1.74M 0.02% 772
2024
Q3
$13.8M Buy
404,386
+311,416
+335% +$8.76M 0.02% 842
2024
Q2
$2.01M Sell
92,970
-249,447
-73% -$5.24M ﹤0.01% 1615
2024
Q1
$7.59M Buy
342,417
+209,776
+158% +$5.12M 0.01% 996
2023
Q4
$3.65M Sell
132,641
-34,091
-20% -$823K 0.01% 1203
2023
Q3
$3.72M Buy
166,732
+59,484
+55% +$1.53M 0.01% 1079
2023
Q2
$2.73M Buy
107,248
+8,773
+9% +$213K 0.01% 920
2023
Q1
$2.2M Sell
98,475
-10,297
-9% -$249K 0.01% 966
2022
Q4
$2.58M Sell
108,772
-38,487
-26% -$894K 0.01% 863
2022
Q3
$2.44M Buy
+147,259
New +$3.31M 0.01% 850
2020
Q1
Sell
-40,990
Closed -$1.14M 1695
2019
Q4
$1.14M Buy
+40,990
New +$1.06M 0.04% 558

Other funds holding VCYT

Qube Research & Technologies (QRT)'s VCYT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 34,273 shares — an estimated $1.1M sold.

Qube Research & Technologies (QRT) first reported a position in VCYT in Q4 2019 and held it in 15 quarters. The position peaked at $26.6M in Q2 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 34,273 Veracyte shares in Q2 2026, an estimated $1.1M.
  • Qube Research & Technologies (QRT) first reported a position in Veracyte in Q4 2019 and held it in 15 quarters.
  • Qube Research & Technologies (QRT)'s Veracyte position peaked at $26.6M in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.